Audet Juliette Berangere 4
4 · NewAmsterdam Pharma Co N.V. · Filed Apr 2, 2024
Insider Transaction Report
Form 4
Audet Juliette Berangere
See Remarks
Transactions
- Award
Option (right to buy)
2024-04-01+250,000→ 250,000 totalExercise: $21.37Exp: 2034-04-01→ Ordinary Shares (250,000 underlying)
Footnotes (2)
- [F1]The Reporting Person resigned from the Issuer's board of directors, effective April 1, 2024, in light of her appointment as the Issuer's Chief Business Officer ("CBO"). The option reported herein was granted in connection with the Reporting Person's appointment as CBO.
- [F2]25% of the shares underlying the option will vest on April 1, 2025, the one-year anniversary of vesting start date, with the remaining shares vesting in equal monthly installments thereafter for three years, subject to the Reporting Person's continued service through each such date.